Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

PaperCitations, authors & open-access status

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 599 citations, 2009 year and closed oa status.

599
Citations
2009
Year
closed
OA Status

Related on ScholarIQ

Giovanni Scambia
Author
The Lancet Oncology
Journal
Venous Thromboembolism Diagnosis and Management
Topic
Venous Thromboembolism Diagnosis and Management
Topic
Chemotherapy-induced cardiotoxicity and mitigation
Topic
Neutropenia and Cancer Infections
Topic
470M+ articles · free account